Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net loss	$ (1,197)	$ (819)
Adjustments to reconcile net loss to net cash used for operating activities:
Depreciation and amortization	96	162
Amortization of debt discount and deferred financing costs		5
Stock-based employee compensation	254	151
Series C Preferred issued in settlement of indemnity claim		417
Common Stock received as settlement of 16b claim		(325)
(Loss) gain on derivative liability	(64)	8
Changes in operating assets and liabilities:
Accounts receivable, net	591	74
Prepaid expenses and other assets	9	(23)
Accounts payable	74	65
Accrued Compensation	(41)	36
Other accrued liabilities		(104)
Deferred revenue	(38)	20
Net cash used in operating activities	(316)	(333)
Cash flows from investing activities:
Acquisition of property and equipment	(2)
Net cash used in investing activities	(2)
Cash flows from financing activities:
Net proceeds from issuance of short-term debt		125
Proceeds from exercise of warrants for cash		213
Proceeds from exercise of stock options		9
Net cash provided by financing activities	29	347
Effect of exchange rate changes on cash and cash equivalents		1
Net decrease in cash and cash equivalents	(289)	15
Cash and cash equivalents at beginning of period	486	307
Cash and cash equivalents at end of period	197	322
Supplemental disclosure of cash flow information:
Interest paid
Income tax paid
Non-cash financing and investing transactions:
Dividends on preferred shares	423	91
Accretion of beneficial conversion feature on convertable preferred shares	55	659
Cashless exercise of warrants		202
Conversion of Series B Preferred Stock into Common Stock		$ 140